Cargando…

CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research

CRISPR/Cas (clustered regularly interspaced short palindromic repeats linked to Cas nuclease) technology has revolutionized many aspects of genetic engineering research. Thanks to it, it became possible to study the functions and mechanisms of biology with greater precision, as well as to obtain gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryczek, Natalia, Hryhorowicz, Magdalena, Zeyland, Joanna, Lipiński, Daniel, Słomski, Ryszard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004187/
https://www.ncbi.nlm.nih.gov/pubmed/33801123
http://dx.doi.org/10.3390/ijms22063196
_version_ 1783671866063323136
author Ryczek, Natalia
Hryhorowicz, Magdalena
Zeyland, Joanna
Lipiński, Daniel
Słomski, Ryszard
author_facet Ryczek, Natalia
Hryhorowicz, Magdalena
Zeyland, Joanna
Lipiński, Daniel
Słomski, Ryszard
author_sort Ryczek, Natalia
collection PubMed
description CRISPR/Cas (clustered regularly interspaced short palindromic repeats linked to Cas nuclease) technology has revolutionized many aspects of genetic engineering research. Thanks to it, it became possible to study the functions and mechanisms of biology with greater precision, as well as to obtain genetically modified organisms, both prokaryotic and eukaryotic. The changes introduced by the CRISPR/Cas system are based on the repair paths of the single or double strand DNA breaks that cause insertions, deletions, or precise integrations of donor DNA. These changes are crucial for many fields of science, one of which is the use of animals (pigs) as a reservoir of tissues and organs for xenotransplantation into humans. Non-genetically modified animals cannot be used to save human life and health due to acute immunological reactions resulting from the phylogenetic distance of these two species. This review is intended to collect and summarize the advantages as well as achievements of the CRISPR/Cas system in pig-to-human xenotransplantation research. In addition, it demonstrates barriers and limitations that require careful evaluation before attempting to experiment with this technology.
format Online
Article
Text
id pubmed-8004187
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80041872021-03-28 CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research Ryczek, Natalia Hryhorowicz, Magdalena Zeyland, Joanna Lipiński, Daniel Słomski, Ryszard Int J Mol Sci Review CRISPR/Cas (clustered regularly interspaced short palindromic repeats linked to Cas nuclease) technology has revolutionized many aspects of genetic engineering research. Thanks to it, it became possible to study the functions and mechanisms of biology with greater precision, as well as to obtain genetically modified organisms, both prokaryotic and eukaryotic. The changes introduced by the CRISPR/Cas system are based on the repair paths of the single or double strand DNA breaks that cause insertions, deletions, or precise integrations of donor DNA. These changes are crucial for many fields of science, one of which is the use of animals (pigs) as a reservoir of tissues and organs for xenotransplantation into humans. Non-genetically modified animals cannot be used to save human life and health due to acute immunological reactions resulting from the phylogenetic distance of these two species. This review is intended to collect and summarize the advantages as well as achievements of the CRISPR/Cas system in pig-to-human xenotransplantation research. In addition, it demonstrates barriers and limitations that require careful evaluation before attempting to experiment with this technology. MDPI 2021-03-21 /pmc/articles/PMC8004187/ /pubmed/33801123 http://dx.doi.org/10.3390/ijms22063196 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ryczek, Natalia
Hryhorowicz, Magdalena
Zeyland, Joanna
Lipiński, Daniel
Słomski, Ryszard
CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
title CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
title_full CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
title_fullStr CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
title_full_unstemmed CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
title_short CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
title_sort crispr/cas technology in pig-to-human xenotransplantation research
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004187/
https://www.ncbi.nlm.nih.gov/pubmed/33801123
http://dx.doi.org/10.3390/ijms22063196
work_keys_str_mv AT ryczeknatalia crisprcastechnologyinpigtohumanxenotransplantationresearch
AT hryhorowiczmagdalena crisprcastechnologyinpigtohumanxenotransplantationresearch
AT zeylandjoanna crisprcastechnologyinpigtohumanxenotransplantationresearch
AT lipinskidaniel crisprcastechnologyinpigtohumanxenotransplantationresearch
AT słomskiryszard crisprcastechnologyinpigtohumanxenotransplantationresearch